Table 1.
p16 positive HNSCC patients | p16 negative HNSCC patients | ||||
---|---|---|---|---|---|
Characteristics | Subtype | No. of cases (%) | Characteristics | Subtype | No. of cases (%) |
Age | <60 | 18 (69.2) | Age | <60 | 35 (49.3) |
≥60 | 8 (30.8) | ≥60 | 36 (50.7) | ||
Gender | Male | 23 (88.5) | Gender | Male | 54 (76.1) |
Female | 3 (11.5) | Female | 17 (23.9) | ||
Pathologic stage | Stage I | 1 (3.85) | Pathologic stage | Stage I | 5 (7.0) |
Stage II | 3 (11.5) | Stage II | 5 (7.0) | ||
Stage III | 1 (3.85) | Stage III | 9 (12.7) | ||
Stage IV | 10 (38.5) | Stage IV | 44 (62.0) | ||
NA | 11 (42.3) | NA | 8 (11.3) | ||
Pathologic T | T1–T2 | 10 (38.5) | Pathologic T | T1–T2 | 20 (28.2) |
T3–T4 | 7 (26.9) | T3–T4 | 43 (60.5) | ||
Tx | 9 (34.6) | Tx | 8 (11.3) | ||
Pathologic N | N0 | 3 (11.5) | Pathologic N | N0 | 16 (22.5) |
N1–N3 | 12 (46.2) | N1–N3 | 48 (67.6) | ||
Nx | 11 (42.3) | Nx | 7 (9.9) | ||
Vital status | Alive | 22 (84.6) | Vital status | Alive | 46 (64.8) |
Dead | 4 (15.4) | Dead | 25 (35.2) |
HNSCC = head and neck squamous cell carcinoma, NA, Nx, Tx = pathologic stage is unknown.